treatment

Outlined below are treatment protocols. You may also download a more detailed treatment overview here from the website by following the links contained in each treatment condition. You will require the Adobe Reader™to be installed on your computer to view these files which are stored in Portable Document Format (PDF).

Acne For more information download the The Q.Light® ACNE CARE brochure from this site by clicking here

For use in medical practices, clinics, specialized treatment centres, beauty salons and for treatment at home.

The main applications for Q.Light® care for ACNE therapy are:

Common acne
Acne vulgaris
- acne comedonica
- acne papulpustulosa
- acne conglobata

About acne
Acne is a dermatological disease that affects about 40% of the population between the ages of 12 to 30 years. Acne is a skin disorder which both physicians and beauticians are frequently confronted with.
Common acne / Acne vulgaris
Common acne is one of the most widespread skin disorders. It typically begins during puberty, often - but not always - subsiding when patients are in their thirties. Depending on the severity of the disorder, acne vulgaris can take on three different forms:
   1 - Acne comedonica
Acne comedonica is characterised by the predominant presence of open and closed comedones appearing in varying numbers and intensities but mainly in the facial region, which are very distressing for patients.
   2 - Acne papulopustulosa
In some cases as the inflammation progresses, painful papules tend to appear, often leaving behind visible scars after healing and thus provoking significant emotional distress.
   3 - Acne conglobata
This is the severest form of common acne. Acne conglobata is characterised by the concurrent presence of comedones, pustules, indurated papules and abscesses with interconnecting sinuses that affect large skin regions. They often develop on the back and nape of the neck; in this latter case the condition is termed acne inversa. Patients are generally 'stigmatized' by numerous scars that can be very pronounced and disfiguring.

Acne and light therapy mechanisms
Q.Light® provides the correct wavelengths shown to stimulate many important reparative factors to both reverse and control this skin condition.
Basically as part of its reproduction and metabolism process, the Propionil- bacterium Acnes (P Acne bacteria) releases a certain pigment called porphyrin. Porphyrin molecules, on absorbing photons, become chemically active and transform into a state of aggregation that can result in several formations. One of the formations is a free oxygen radical that attacks the cell membrane and leads to the destruction of the P. acne bacterium. The efficacy of this photochemical process is determined by the concentration of porphyrin, dose of photon energy and wavelength of the photons.

How to treat acne with Q.Light®

Scientific studies and empirical reports show individual cases of acne can be significantly reduced or even completely healed by regular exposure to Q.Light®. As individual treatment sessions are very short Q.Light® therapy can easily be integrated into traditional - local or systemic - regimens of acne therapy. The average dose applied is 9.6 J/cm2 once a day.

For optimal results it is recommended to clean the area to be treated with a mild cleanser. Then direct the Q.Light® beam at a right angle to the treatment area. The treatment time per session is 15 min at the max treatment distance.

Pain For more information download the The Q.Light® PAIN CARE brochure from this site by clicking here

For general acute and chronic care. The Q.Light® system is especially designed for the application of acute and chronic pain care treatment in medical practices, clinics, specialised treatment centres, nursing homes/services and for treatment at home.

Systemic mechanisms of anti-inflammatory, immunomodulating effects of visible light
Research on wound healing with visible light demonstrates how the biopositive aspects of light therapy are directed to the blood composition through the action of light on the superficial skin micro-vessels.

The overall action can be described as the following:
Light activated blood is able to influence the total volume of blood in the body within a period of 90 minutes. Changes are observed to continue, at a slower rate, for up to 24 hours after irradiation. The dose of emitted light applied for treatment is 12J/cm2 with a wavelength of 385 to 780 nm (385 to 1700 nm using the professional PRO) and a polarisation degree of 95%

The treatment result can be summarized as the following:

immediate effect on blood changes are due to the transcutaneous photo-modification with a fast (30-90 minute) translation of light-induced changes to the whole circulating volume of blood.
Changes in blood cells and plasma of the entire circulating blood are induced
Increased functional activity of monocytes, granulocytes, lymphocytes, platelets, improvement of rheologic transport and gas-transport properties of erythrocytes
Induced lipid peroxidation levels in the erythrocyte membrane and plasma
modified haemostasis
significant decreases in the plasma content of pro-inflammatory cytokines and increased levels of anti-inflammatory II10 and IFN-g, modulated growth content factors and increased growth-promoting plasma properties for keratinocytes, endotheliocytes, fibroblasts.

The changes demonstrate the regulatory nature of visible light therapy and its therapeutic efficacy for PAIN CARE even in cases of chronic pain.

General Information on Q.Light® for PAIN CARE
The Q.Light® Therapy System is suited for use in prophylactic (preventative) treatment therapies and rehabilitation. It is a practical, hi-tech method of treatment. This innovative medical technology, made in Switzerland, is already used by medical professionals in many countries throughout Europe. Anyone can benefit from this effective and low cost treatment.

Q.Light® is becoming increasingly popular in physiotherapy, rehabilitation and sports medicine.

During the application of Q.Light® therapy the resulting biopositive effects strengthen the defense forces and the entire metabolism is stimulated in addition to the inflammation-retarding and pain-relieving effects. Q.Light® treatment has been shown to succeed in reducing pain where classic treatment methods have failed.

Q.Light® provides consistent intensity, based on an exactly defined spectrum that is proven to be effective in pain treatment. Moreover, Q.Light® therapy will certainly play an important role in individual health due to its ease of use and reasonable price.

How to treat pain with Q.Light®

For optimal results the Q.Light® for PAIN CARE therapy should be applied on a daily basis. The average dose applied to the region of pain is around 12J/cm2 to 24J/cm2. The light beam is directed at a right angle to the area to be treated. Q.Light® can be an ideal complementary treatment to a variety of pain management programmes. Its beneficial influence can affect the patient's general condition and pain symptoms.

Q.Light® therapy is applied for just a few minutes - 10 to 15 minutes per treatment is ideal, mainly twice per day, but in acute stages sometimes three to four times per day. Direct the light onto the area to be treated from a distance of approximately 30 to 40 cm. In cases of joint treatment it is possible to extend the therapy without danger.

Side effects or contraindications have not been reported.

Wound Care For more information download the The Q.Light® WOUND CARE brochure from this site by clicking here

For general wound care and the treatment of slow healing wounds. The Q.Light® system is especially designed for the application of wound care treatment in medical practices, clinics, specialised treatment centres, nursing homes/services and for treatment at home.

The main applications for Q.Light® WOUND CARE are:

Stasis Ulcers / Leg Ulcers
Decubitus Ulcers / Pressure Sores
Diabetic Gangrene
Surgical Wounds
Injury Wounds
Burns

Systemic mechanisms of anti-inflammatory, immunomodulating and wound healing effects of visible light.
Research on wound healing with visible light demonstrates that influences are directed to the blood composition through action on the superficial skin microvessels
The overall action can be described as the following:
Light activated blood is able to influence the total volume of blood in the body within a period of up to 90 minutes. Continuing blood changes are observed at a slower rate for up to 24 hours after light therapy has been applied. The dose of emitted light is 12 J/cm2 with a wavelength of 385 to 780 nm (386 to 1700 nm using the professional PRO).

The treatment result can be summarised as the following:

immediate effect on blood changes are due to the transcutaneous photo-modification with a fast (30-90 minute) translation of light-induced changes to the whole circulating volume of blood.
Changes in blood cells and plasma of the entire circulating blood are induced
Increased functional activity of monocytes, granulocytes, lymphocytes, platelets, improvement of rheologic transport and gas-transport properties of erythrocytes
Induced lipid peroxidation levels in the erythrocyte membrane and plasma
modified haemostasis
significant decreases in the plasma content of pro-inflammatory cytokines and increased levels of anti-inflammatory II10 and IFN-g, modulated growth content factors and increased growth-promoting plasma properties for keratinocytes, endotheliocytes, fibroblasts.

The changes demonstrate the regulatory nature of visible light therapy and its therapeutic efficacy for WOUND CARE even in cases of slow healing wounds

General information on Q.Light® for WOUND CARE
Q.Light® Light therapy is effective in different phases of wound healing by arresting inflammations, alleviating pain, activating the immune response, improving perfusion and revascularization, increasing lymphatic drainage and generally improving metabolism.

All of these effects support the body's power of self-healing. In the case of chronic wound healing disorders, light has a significantly positive influence on pathological wound environments. Wounds heal more effectively if newly formed capillaries increase the blood supply, if increased lymphatic drainage dissipates edemas, if an improved immune response fights infections and metabolism is reactivated. Therefore, the Q.Light® PRO beam is polarized and within a range from 385 to 1700 nm (depending on system chosen) and produces a power density of 40 mW/cm2 at max. treatment distance. The Q.Light® beam can therefore penetrate deep into tissue.

Q.Light® Light Therapy is of enormous benefit for patients, doctors and nursing staff. As individual treatment sessions are very short, it can easily integrated into standard wound care procedures. After swabbing the wound, light therapy is applied for a few minutes to the wound area and surrounding tissue. Side effects or contraindications have not been reported.

How to treat wounds with Q.Light®

For optimal results the Q.Light® WOUND CARE therapy should be applied on a daily basis. The average dose applied to wounds must be 12J/cm2. The light beam is directed at a right angle to the area under treatment.
Typically, wound healing takes place in three interlinking phases

endogenous purification
granulation
epithelialization
NOTE: In the initial treatment phase of chronic wounds some patients' wounds may respond to light treatment with rapid closure at the edge of the wound site. In these cases light therapy should be discontinued for a few days for the system to adjust. Recommence light therapy after this short refractory period according to the treatment indications highlighted above.

Burn wounds

The Q.Light® for WOUND CARE therapy approach can reduce the need for surgery in the treatment of deep dermal burns, if applied immediately after admission to hospital. Within this group of patients, the use of light therapy accelerates wound healing and allows for early pressure therapy, therefore reducing hypertrophic scarring and contractures. In addition shortened hospitalization results in cost benefits and increased patient satisfaction. This form of light therapy has become first choice for deep dermal burns in many hospitals and specialist burn centres.

Psoriasis For more information download the The Q.Light® PSORIASIS CARE brochure from this site by clicking here

The Q.Light® therapy approach is designed for the treatment of psoriasis and neurodermatitis in medical practices, clinics, specialist treatment centres, nursing home/services and for treatment at home.
The main applications for Q.Light® therapy are:

Psoriasis
Neurodermatitis
Atopic-dermatitis

General information on the treatment of psoriasis
Psoriasis has no cure, but a wide range of treatments can give people control over their condition. No single treatment works for everyone, but light therapy is likely to work in most cases.

The traditional approach is to start with topical treatments and phototherapy until a satisfactory combination of results is found. The goal is to discover a treatment that achieves the best results and the fewest side effects.

General approach
Light Therapy is an effective treatment and can improve the condition of the skin and reduce swelling, redness, flaking and itching. In some cases the treatment can clear the skin (this is called "clearance" or "remission" of psoriasis). Light therapy can be used for a period of time to reduce flare-ups of the lesions. Because psoriasis is chronic and unpredictable, it can be challenging to treat. It often improves and worsens in a natural cycle.

Psoriasis treatments - Treatments for psoriasis can be divided into three basic categories:

Topical treatment (external treatments)
Phototherapy - or a combination of light therapy and medication
Systemic (internal) medications taken orally or by injection.

What is psoriasis
Psoriasis is a disorder in which angry red lesions appear on the skin, multiply and scale over with silvery patches.

The word 'psoriasis' comes from the ancient Greek and means 'to itch'. Red eruptions appear on the surface of the skin and begin to itch. These areas form plaques over the reddened lesions. The plaques resemble multi-layered scales of skin. Psoriasis varies in intensity from a few random spots to a massive outbreak covering the entire body and requiring hospitalization.

Psoriasis has a tendency to be genetically inherited. Recently, it has been classified as being an autoimmune disorder (the body's immune system turning in on itself). This disorder can originate in childhood or adulthood. It has been reported to form as early as birth but for many the condition does not appear until later in child or adulthood. However, once psoriasis appears there are only remissions and relapses of varying degrees as it is viewed after onset to be a chronic condition.

Psoriasis is reactive. It has triggers which can cause the body to go from a very mild case to a severe case often within a few days. There are factors, such as sunlight, which help decrease severity. Psoriasis occurs in two percent of the population. It can be a mildly annoying problem or can destroy the self-esteem and life of the person affected. Although it is not contagious, it is a disfiguring condition that can alienate coworkers and acquaintances.

Arthritis can also stem from psoriasis, attacking the joint spaces, giving the psoriasis sufferer another disease process to deal with. Patches, chronic itching and flaking, although not life threatening, impact on both the self-esteem and lifestyle of the psoriasis victim. Time and money are spent trying to keep the condition under control . Most therapy costs are covered by NHS treatment or private insurance but over time the costs become a financial burden.

How to treat psoriasis with Q.Light®
General Psoriasis care

Q.Light® Therapy can offer relief for people with psoriasis conditions. As individual treatment session are short, it can easily be integrated into standard psoriasis care programme depending on indication. The average dose applied to psoriasis is around 12J/cm2.

Q.Light® therapy is applied for just a few minutes once or twice per day. In order to use the Q.Light® system effectively, the skin should be cleansed before exposure to the light. Apply the visible polarised light from a distance of approximately 30 to 40 cm to the skin surface for 4 to 6 minutes over each area.

Special dermatological creams can be applied before or after the light treatment. Any residue of cream should be wiped away if applied before commencing the light treatment. Q.Light® therapy offers relief of itching within days. The condition normally improves within the first two weeks however in some cases it is very difficult to achieve total regeneration of the skin. It is recommended to continue long term Q.Light® Therapy after initial symptom response to regulate the immune system and moderate future flare-ups.

Side effects and contraindications have not been reported. It is advisable to check longer lasting skin conditions with a specialist to receive additional professional advice.

The beneficial effect and regenerating effect of the Q.Light® Therapy can be used to support various forms of skin treatments.

Q.Light® Seasonal Affective (SAD) Filter Module For more information download the The Q.Light® SAD CARE brochure from this site by clicking here

Spectrum: 400 - 780 nm
The SAD Care Module is specially designed for the application of neurological, neuro-immunological and endocrinological treatments in medical practices, clinics, specialist treatment centres, nursing homes/services and for treatment at home.
The main applications of Q.Light® SAD CARE are:

SAD/Seasonal Affective Disorder
Depression

Scientific research has shown that light therapy is the most effective, natural treatment for this distressing seasonal condition. Cost effective, natural and without side effects!

Neuroimmunomodulating effects induced by visible light
The immune system is susceptible to a variety of stresses. Recent work in neurobiology has begun to define how mood alteration, stress, the seasons, and daily rhythms can have a profound effect on immune response through hormonal modification. Central to these factors may be the influence of light thorough an eye-brain hormonal functioning.

In human beings, only visible light (400-700nm) is registered by the retina of the eye. This light energy is then transduced and delivered to the visual cortex and, by an alternative pathway, to the suprachiasmatic nucleus (SCN), the hypothalmic region that directs circadian rhythm. Visible light exposure also modulates the pituitary and pineal glands, leading to neuroendocrine changes. Melatonin, norepinephrine and acetylcholine decrease with light activation, whereas cortisol, serotonin and dopamine levels increase.

The synthesis of vasoactive intestinal polypeptide (VIP), gastrin releasing peptide (GRP) and neuropeptide Y (NPY) has been shown to be modified by light. These induced neuroendocrine changes can lead to alterations in mood and circadian rhythm as well as immune modulation. An alternative pathway for immune modulation by light is through the skin. Visible light (400-700 nm) can penetrate epidermal and dermal layers of the skin and may directly interact with circulating lymphocytes to regulate immune function.

It is therefore important for treatment to control the intensity, treatment distance and wavelength of emitted light. In conclusion, light should be regarded as an effective medication with strong potential to cure SAD symptoms. Light is a versatile therapeutic tool that can be combined with other therapies.

Some studies have reported positive responses in patients with non-seasonal depression, premenstrual syndrome (late luteal dysphoria), bulimia, and alcohol withdrawal symptoms. Further work in these areas is clearly warranted. Beneficial results have also been obtained in certain cases by using the known capacity of light administration and light restriction to shift circadian rhythms. Cases where this therapy have been used include those of patients with stable circadian rhythm abnormalities such as delayed sleep phase syndrome (DSPS) or advanced sleep phase syndrome (ASPS). Patients with DSPS have trouble falling asleep and waking up at conventional times; they can be helped by being exposed to bright light in the morning and having their environmental light restricted in the afternoon and evening. ASPS is most common in the elderly; their tendency to fall asleep and wake at inconveniently early hours can be alleviated if they are exposed to bright light at night.

Therapeutic guidelines for the treatment of SAD
1. Encourage daily walks outdoors; the patient may look up at the sky but never directly into the sun. Enhance indoor lighting with regular lamps and fixtures.
2. Set a timer on a light to go on early in the morning in the patient's bedroom. Consider a dawn simulator for a natural artificial dawn.
3. Initiate Q.Light® therapy with 10,000 lux starting with 30 minutes in the morning or at any time of day that is convenient for the patient. Increase the duration if symptoms become more severe, up to 45 minutes twice a day.
4. Aerobic exercises, preferably in combination with exposure to bright light may be quite helpful.
5. To help the patient manage stress, suggest vacations (preferably in the southern hemisphere) at strategic times, and provide support, counselling and therapy.

How to treat SAD with Q.Light®

For optimal results with Q.Light® SAD CARE therapy, it is important to apply an effective dose. To receive adequate biological response an average dose is applied to the eyes for 30 mins at the minimum treatment distance. The light beam is directed, from the front, at a right angle to the face. The treatment should be applied on a daily basis. It is not necessary to look directly into the light beam! One can read a book or magazine whilst receiving the light therapy treatment dose.

Some studies have reported positive responses in patients with non-seasonal depression, premenstrual syndrome (late luteal dysphoria), bulimia, and alcohol withdrawal symptoms. Beneficial results have also been obtained by using the known capacity of light administration and light restriction to shift circadian rhythms.

References

| Psoriasis | Wound | Acne | Pain | SAD |

Research backup on psoriasis
Immunologic mechanisms in psoriasis

Gottlieb AB.. J Am Acad Dermatol. 1988;18:1376-1380.Combination therapy with alefacept and light for treatment of psoriasis

Koo J.. Presented at Hawaii Dermatology Seminar; February 14-22, 2003; Maui, Hawaii. Poster. Treatment of psoriasis, Part I: topical therapy and phototherapy

Lebwohl M, Ali S.. J Am Acad Dermatol. 2001;45:487-498.Treatment of psoriasis. Part II: systemic therapies.

Lebwohl M, Ali S. J Am Acad Dermatol. 2001;45:649-661. The immunologic and genetic basis of psoriasis.

Nickoloff BJ. Arch Dermatol. 1999;135:1104-1110.Combination therapy with alefacept plus light for treatment of psoriasis
Ortonne JO, Khemis A.. Presented at International Psoriasis Symposium; June 2003;Inflammatory skin diseases, T cells, and immune surveillance.

Robert C, Kupper TS. N Engl J Med. 1999;341:1817-1828

Improvement of rheologic parameters, ligand- and oxygen-binding capacity of erythrocytes of circulating blood after exposure of the body surface to visible polarized light. K.A.Samoilova, K.D.Obolenskaya, A.V.Vologdina, N.V.Mineeva, N.Yu.Romanenko, M.F.Balljuzek: Published: 8th Congress of European Society for Photobiology. Book of Abstracts, P106, p.145, Granada (1999)

Research Backup on wound healing
The effect of polarized-light on wound healing
S. Monstrey, H. Hoeksema, H. Saelens, K. Depuydt, M. Hamdi, K. Van Landuyt and P. Blondeel
Department of Plastic Surgery, University Hospital Gent, Belgium Published: European Journal of Plastic Surgery – 2000
A conservative approach for deep dermal burn wounds using polarised-light therapy

S. Monstrey, H. Hoeksema, H. Saelens, K. Depuydt, M. Hamdi, K. Van Landuyt and P. Blondeel
Department of Plastic Surgery, University Hospital Gent, Belgium
Published: British Journal of Plastic Surgery – 2002

On the mechanism of enhancement of wound healing by visible incoherent polarized light: stimulation of the human keratinocyte and fibroblast proliferation in vitro by soluble factors of the circulating blood.
M.I.Blinova, K.A.Samoilova, N.M.Yudintzeva, N.M.Kalmykova: Published: 8th Congress of European Society for Photobiology. Book of Abstracts, P108, p.145, Granada (1999).

General
Effect of NASA Light-Emitting Diode (LED) Irradiation on Wound Healing.
Cevenini V, Stinson H, Ignatius R, Martin T, Cwiklinski J, Philippi AF, Graf WR, Hodgson B, Gould L, Kane M, Chen G, Caviness J
Published: Journal of Clinical Laser Medicine and Surgery. 2001;19:305-314

2. Degree Burn Wounds on face and neck- 5 patients
Gera, Germany - Dr. Stotz,
Profound pain reduction and optimal wound healing was achieved without practically no scar formation
Diabetes mellitus Type 2
Nursing Home Rorschach, Switzerland
Mr A. is born 19.10.1920 and came back to our nursing home after hospitalization with wounds on the heels.
Treatment time range May – August 04

Research backup on acne

An action spectrum for blue and near ultraviolet inactivation of Propionibacterium acnes; with emphasis on a possible porphyrin photosensitisation.
Kjeldstad B, Jhonsson Photochemistry-Photobiology 1986: 43(1); 67-70

Singlet oxygen (1 delta g) generation from coproporphyrin in Propionibacterium acnes on irradiation.
Arakane K, Ryu A, Hayashi C, Masunaga T, Schinmoto K, Mashiko S, Nagano T, Hirobe M. Biochem Biophys Res Commun 1996; 223 (3): 578-82.

Effect of Visible Light on Reactive Oxygen Species Production
R. Lubart,1 H. Friedmann,1 R. Lavie,1 N. Grossman,2 M. Sinyakov and S. Belotsky
Department of Chemistry and Physics, Department of Life Sciences
Bar-Ilan University, Ramat-Gan 52900, Israel

Visible light promotes proliferation of normal skin cells
Grossman, N., Reuveni, H., Halevy, S., Lubart, R:, J. Invest.
Dermatol., 102649A (1994)

Research Backup on pain care

The use of monochromatic Infrared Energy Therapy in Podiatry. Podiatry
Carnegie D.
Published: Management. Nov/Dec. 2002. 129-34

Restoration of sensation, reduced pain, and improved balance in subjects with diabetic peripheral neuropathy: a double-blind, randomized, placebo-controlled study with monochromatic near-infrared treatment - Emerging Treatments and Technologies
by David R. Leonard, M. Hamed Farooqi, Sara Myers
Published: Diabetes Care, Jan, 2004

Risk of falls in elderly patients is markedly reduced through improvement in sensation, balance, and gait with infrared photo energy, and other physical therapy (Abstract).
Kochman AB:
Published: J Geriatric Phys Therapy 25:29, 2002

Changes of cytokine content in human blood after ist in vivo and invitro exposure to visible polarized light at therapeutic dose.
K.A.Samoilova, D.I.Sokolov, K.D.Obolenskaya.
In: Abstracts. 13th International Congress on Photobiology and 28th Annual Meeting American Society for Photobiology. San Francisco, 2000, N 327, p.108..

Practical experience and references with Q.Light® pain care

Geriatric therapy

Doctor in charge, Dr. Stotz, Gera, Germany,
Various patients with Haematomas and Thorax Prellungen,
Q.Light in combination with laser - excellent results by reducing pain
Sportsmedicine

Masseur Therapist, Mr. Borchert, FC Erzgebirge Aue, Germany,
Constantly treats injured players, specially with haematomas, muscle tension and tissue damages.
Q.Light in combination with physiotherapy faster healing and effective reduction of pain.

Seasonal Affective Disorder (SAD) and Other Light Influences on Brain/Mood

Research Backup on SAD
Light suppresses melatonin secretion in humans
Lewy,A J,Wehr TA,Goodwin FK,Newsome DA,Markey SP.
Published:Science.1980;210:1267-1269.

A description of the syndrome and preliminary findings with light therapy
Resenthal NE,Sack DA.Gillin JC,et al.Seasonal affective disorder.
Published: Arch Gen Psych.1984;41:72-80

Canadian consensus for the treatment of seasonal affective disorder
Lam RW, Levit A (eds)..
Canadian J of Diagnosis 1998; Supplement; 2 – 15:

Lichttherapie 3. edition
Zulley J, Wirz-Justice, A (eds). Regensburg:
S.Rodner Verlag, 1999

Beginning to see the light.
Wirz-Justice A,
Commentary. Arch Gen Psychiatry 1998; 55:861-862; auch alle Originalartikel pp 875 – 896

Seasonal Affective Disorder and Beyond: Light treatment for SAD and non SAD conditions
Lam RW (ed). Washington DC American Psychiatric Press 1998

Practical experience with Q.Light® SAD care
Sports medicine
Masseur FC Erzgebirge Aue, Germany, Therapist Mr. Borchert,
Treatment of players before a match (10 Min. of Q.Light® to the eyes)
Improved concentration and less aggression

Psycotherapy
Klinik Hohe Mark, Oberursel
Addiction Patients (Alcohol and Drug addicts)
Strong reduction of withdrawal sympomes, Aufhellen der Psyche, Faster detoxification

PRIVACY STATEMENT

DISCLAIMER Medilux Healthcare Limited markets medical products and services on behalf of Manufacturers and Providers. We may discuss with patients and their doctorsin general terms their potential suitability for a stated condition but we do not examine or diagnose patients or conduct tests or analysis, nor are we authorised to commit our Principals to any diagnosis, outcome or precise costing or to enter into any formal or informal agreement on their behalf. Customers contract with our Principals directly and we will not be liable in any way for the success, failure or other outcome of any treatment or the accuracy of diagnosis given.

Where we offer phototherapy and other devices for sale, this is on the basis of the Manufacturers' representations as to quality and efficacy. Any further guidance as to conditions that may benefit from use of the goods is based purely on our own opinions and beliefs regarding general application. We do not guarantee that goods will be suitable or effective for all purchasers and do not advise on individual cases. We recommend that customers seek qualified medical advice before commencing treatment.